Company profile: Cerbios
1.1 - Company Overview
Company description
- Provider of chemical and biological active pharmaceutical ingredients (APIs), including high-potency APIs (HPAPIs) and antibody-drug conjugates (ADCs), with manufacturing and development capabilities.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cerbios
hVIVO
HQ: United Kingdom
Website
- Description: Provider of human challenge trials to accelerate early clinical development in respiratory and infectious diseases; volunteer recruitment via FluCamp; virology and immunology lab services (hLAB) for preclinical and clinical respiratory drug and vaccine R&D; drug development consultancy and clinical trial design/execution through Venn Life Sciences; and vaccine development via Imutex.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full hVIVO company profile →
Curapath
HQ: Spain
Website
- Description: Provider of polymer and lipid-based drug delivery systems—including polymer and lipid nanoparticles—offering custom design through preclinical development to commercial-scale pharmaceutical manufacturing, plus drug conjugation and cross-linking services to enhance stability, reduce toxicity, and improve bioactivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curapath company profile →
Upperton Pharma Solutions
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical contract development and manufacturing services for biotech and pharma, offering formulation development (powders, capsules, tablets) from feasibility to clinical manufacture; Phase 1–3 clinical supply; process scale-up and optimisation; registration activities; analytical development and validation; and UpperNose, a nasal product development platform for small and mid-sized innovators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Upperton Pharma Solutions company profile →
Safety Partners
HQ: United States
Website
- Description: Provider of environmental, health, safety, and regulatory compliance services, including permit and license management, EHS program development and implementation, industrial hygiene, animal care and use support for vivarium setup and compliance, web-based and on-site training, and lab relocation and decommissioning, including permit transfers and decontamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Safety Partners company profile →
NDA Regulatory Service
HQ: Germany
Website
- Description: Provider of regulatory affairs consultancy and support across Europe; one of the leading firms in the field, with ~85 employees and offices in Sweden, the UK, and Germany, delivering regulatory support for over 10 years. Munich office founded by a core group of regulatory experts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NDA Regulatory Service company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cerbios
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cerbios
2.2 - Growth funds investing in similar companies to Cerbios
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cerbios
4.2 - Public trading comparable groups for Cerbios
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →